Skip to main content

Table 1 Patient characteristics of the treatment groups.

From: Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine

Variable

FLV

FLV+TJ-43

 

Number

25

25

 

Age, years

40.3 ± 17.3

40.2 ± 16.1

n.s.1)

Sex

   

   Male

18 (72%)

18 (72%)

 

   Female

7 (28%)

7 (28%)

n.s.2)

GSRS total score

2.30 ± 1.18

2.53 ± 1.03

n.s.3)

SDS score

56.0 ± 7.0

56.6 ± 7.8

n.s.1)

  1. FLV = fluvoxamine; TJ-43 = Rikkunshito; GSRS = gastrointestinal symptom rating scale; SDS = self-rating depression scale. mean ± SD. N.s. = not significant.
  2. 1) Student t-test for unmatched data. 2) Fisher exact probability test. 3) Student t-test for unmatched data and Mann-Whitney U test.
Back to article page

BioPsychoSocial Medicine

ISSN: 1751-0759

Contact us